Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hand Deserve Better: global clinical consensus recommendations on surgical gloving practice.

The Journal of hospital infection·2026
Same author

Infection with Helicobacter pylori and the age at onset of coeliac disease in the "HUNT4" survey.

BMC research notes·2025
Same author

Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial.

The Lancet. Rheumatology·2025
Same author

Prevention of viral transmission must be assured before re-use of infusion sets.

European journal of anaesthesiology·2025
Same author

Infection prevention practices can cause hand eczema.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2024
Same author

Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis.

Rheumatology (Oxford, England)·2023

Related Experiment Video

Updated: Jun 9, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

[Tigecycline--a new antibiotic].

Venke Skibeli1, Ingvild Aaløkken, Egil Lingaas

  • 1Statens legemiddelverk, Sven Oftedalsvei 8, 0950 Oslo, Norway. venke.skibeli@legemiddelverket.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|September 1, 2010
PubMed
Summary

Tigecycline, a glycylcycline antibiotic, effectively combats resistant gram-positive and gram-negative bacteria. It offers a crucial treatment option for complicated infections when other antibiotics fail, despite potential serious adverse events.

More Related Videos

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

Related Experiment Videos

Last Updated: Jun 9, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Tigecycline represents a novel class of antimicrobial agents, the glycylcyclines.
  • Structurally, it is derived from tetracyclines.
  • It exhibits broad-spectrum activity against various bacterial pathogens.

Purpose of the Study:

  • To evaluate the efficacy and safety of tigecycline.
  • To highlight its role in treating infections with resistant bacteria.
  • To identify its place in therapy for complicated infections.

Main Methods:

  • Review of existing literature on tigecycline.
  • Analysis of clinical trial data.
  • Assessment of antimicrobial spectrum and resistance patterns.

Main Results:

  • Tigecycline demonstrates effectiveness against both gram-positive and gram-negative bacteria, including aerobes and anaerobes.
  • It is active against bacteria resistant to traditional tetracyclines.
  • Serious adverse events are associated with tigecycline use.

Conclusions:

  • Tigecycline is vital for treating complicated infections of moderate severity when alternative antimicrobials are unsuitable.
  • Its use requires careful consideration of the risk-benefit profile due to potential adverse events.